Error message

An illegal choice has been detected. Please contact the site administrator.

Omnes Capital's investments

Sector 
Industry
Entry Date 
2018
Business 
Co-Investment

World’s largest independent bottler of soft drinks
Headquartered in Netherlands, the company is the global leading independent bottler of soft drinks for retailers and brands focused on Europe and with a presence in the US. It offers the broadest spectrum of products and packaging, and has more than 60 facilities around the world.
Entry Date 
2018
Business 
Venture Capital

Pherecydes Pharma

Specializes in research into innovative and adaptive solutions to fight multi-resistant bacterial infections

Pherecydes Pharma SA specializes in research into innovative and adaptive solutions to fight multi-resistant bacterial infections, using cocktails of natural phages.  
Thanks to its unique expertise, Pherecydes Pharma has managed to develop a large bank of bacteriophages cocktails to fight antibiotic-resistant infections, steadily on the rise since the 1980s.

Sector 
Infrastructure
Entry Date 
2018
Business 
Renewable Energy

Notus

Joint Venture with one of the first independent renewable energy developers in Germany
Notus Energie France is a joint venture between Capenergie 3 and the industrial German developer Notus. It is the French subsidiary of the Notus Group. Its activity is the development, acquisition, construction and operation of solar photovoltaic and wind projects in France. Notus is one of the first independent renewable energy developers in Germany, having already built more than 1 GW in the past 15 years. Expanding internationally, Notus launched its French subsidiary Notus Energie France in 2016 which, since 2016, has been developing more than 15 wind projects with a potential capacity of more than 300 MW. By investing in Notus Energie France, the Fund will support and co-finance these development efforts. The objective of the investment is to transform the development pipeline into wind and solar photovoltaic assets that are fully permitted and ready to be constructed. Additional acquisitions are also being pursued in order to boost the portfolio and transform Notus Energie France into a significant renewable energy platform in France. Notus Energie France is held by Capenergie 3.
Sector 
Industry
Entry Date 
2017
Business 
Co-Investment

World leader in the design, engineering and production of high-end audio mixing consoles for professional end-users
Headquartered in the United-Kingdom, the company designs and manufactures an expanding range of audio mixing consoles and ancillary products for professional end-users across a variety of applications. With more than a hundred of employees, it has an outstanding reputation for innovation, best-in-class performance and reliability in demanding live productions.
Sector 
Industry
Entry Date 
2017
Business 
Co-Investment

European market leader for premium temporary space solutions
Headquartered in Germany, the company provides temporary and modular building solutions for the industrial sector, special events and large missions requiring rapid deployment systems.
Sector 
Healthcare facilities
Entry Date 
2017
Business 
Co-Investment

Leading European provider of services to the dependent and the elderly
Headquartered in France, the company is one of the European leading provider of services to the dependent and the elderly, with more than 30,000 beds.
Sector 
Pharma
Entry Date 
2017
Business 
Venture Capital

Octimet

Development of a clinically de-risked MET kinase inhibitor for the treatment of cancers

Founded in 2016, Octimet Oncology N.V. (Belgium) is a new company (spin-off from Johnson & Johnson) that acts as a translational accelerator, focusing on creating value for investors and patients by providing rapid clinical proof of concept for cancer therapies through innovative clinical development strategies and patient centered biomarker approaches. The current focus is on its clinical stage asset OMO-1, a highly selective small molecule MET inhibitor that will be developed with specific biomarkers, whilst an additional late pre-clinical stage oncology asset 0MO-2 will also enter the portfolio.

Sector 
Business services
Entry Date 
2016
Business 
Co-Investment

Global leading software editor for the simulation of sheet metal forming in the automotive industry
Headquartered in Switzerland, the company is the reference software editor for the simulation of sheet metal forming processes to the automotive industry.
Sector 
Pharma
Entry Date 
2016
Business 
Co-Investment

French pharmaceutical company specialized in complex generics
Headquartered in France with a global footprint, the company is specialised in the manufacturing and distribution of products with challenging formulations.
Sector 
Web
Entry Date 
2016
Business 
Co-Investment

Global provider of web content management
Headquartered in Denmark , the company is a global software company with a strong footprint in the web content and customer experience management.

Pages

NewsRoom
No result found.